Interleukin-5 Receptor alpha-directed Cytolytic Antibody


Benralizumab may treat:

Benralizumab contraindicated conditions:

Benralizumab drug classes:

  • Interleukin-5 Receptor alpha-directed Cytolytic Antibody

Benralizumab pharmacologic actions:

  • Anti-Asthmatic Agents

Benralizumab mechanism of action:

  • Interleukin 5 Receptor alpha-directed Antibody Interactions
  • treatable

The content offered on is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 9/27/2022, 3:58:52 AM